COVID-19
Clinical trials for COVID-19 explained in plain language.
Never miss a new study
Get alerted when new COVID-19 trials appear
Sign up with your email to follow new studies for COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes pill ease long COVID?
Disease control Not yet recruitingThis Phase 3 trial tests whether dapagliflozin, a drug used for diabetes, can improve quality of life in people with long COVID. 192 adults with persistent symptoms for at least 12 weeks after a COVID infection will receive either the drug or a placebo daily for 12 months. The ma…
Matched conditions: COVID-19
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
New antibody drug aims to tackle COVID-19 early
Disease control Not yet recruitingThis early-stage trial tests a new drug called B10-FC, which is a lab-made antibody designed to fight the SARS-CoV-2 virus. The study will first give the drug to 25 healthy volunteers in increasing doses to check safety, then to 10 COVID-19 patients. The main goal is to see if th…
Matched conditions: COVID-19
Phase: PHASE1 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Disease control
Last updated Jun 26, 2026 13:33 UTC
-
Breath sniff test could spot COVID and flu in hospital patients
Diagnosis Not yet recruitingThis study tests whether analyzing chemicals in a person's breath can quickly identify serious respiratory infections like COVID-19, flu, and Legionella in hospitalized patients. Researchers will collect breath samples from 777 adults using a simple bag, then analyze them in a la…
Matched conditions: COVID-19
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Could a single At-Home swab detect COVID, flu, and RSV?
Diagnosis Not yet recruitingThis study will test a new at-home diagnostic test that aims to detect five respiratory viruses—COVID-19, influenza A and B, RSV, and rhinovirus—from a single nose swab. About 2,000 people with cold or flu symptoms will provide samples in simulated home environments. The test's a…
Matched conditions: COVID-19
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Nasal shields aim to stop COVID and flu before they start
Prevention Not yet recruitingThis study tests two nasal protective devices (Noseguard and Noseguard Night) in 2000 adults to see if they can reduce the risk of catching respiratory infections like COVID-19 and influenza. Participants will use the devices as directed for 8 weeks, and researchers will track in…
Matched conditions: COVID-19
Phase: NA • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
Could placental stem cell vesicles ease COVID-19?
Symptom relief Not yet recruitingThis early-stage trial tests a single IV dose of placental stem cell vesicles (XoGlo Pro) against placebo in 64 adults with mild to moderate COVID-19. The main goal is safety, with a secondary focus on how quickly symptoms resolve. Researchers aim to see if these tiny cell partic…
Matched conditions: COVID-19
Phase: PHASE1, PHASE2 • Sponsor: Kimera Labs Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
France launches massive virus surveillance in GP clinics
Knowledge-focused Not yet recruitingThis study will track which respiratory viruses—like flu, COVID-19, and RSV—are circulating in French primary care clinics each winter. Up to 25,000 patients with cold or flu symptoms will provide a saliva or nose swab sample. The goal is to monitor virus activity and help guide …
Matched conditions: COVID-19
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Pandemic babies: did lockdowns shape preterm infant brains?
Knowledge-focused Not yet recruitingThis study looks at 120 preterm infants born before 34 weeks to see if those born during the COVID-19 pandemic (2020-2021) develop differently than those born after (2023-2024). Researchers will test thinking, movement, and language skills using play-based assessments. The goal i…
Matched conditions: COVID-19
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New brain scan probes lingering COVID mysteries
Knowledge-focused Not yet recruitingThis study uses a special PET scan to look for signs of inflammation in the brains of people with Post-COVID syndrome. Researchers want to learn more about why some people have long-lasting symptoms after a COVID-19 infection. Ten Mayo Clinic patients who had COVID-19 and are exp…
Matched conditions: COVID-19
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
COVID-19 ECMO patients face bleeding and clot risks, new study investigates
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 50 adult ICU patients with COVID-19 who needed a life-support machine called ECMO. The goal is to understand how often bleeding and dangerous blood clots happen, and how blood transfusions and blood thinners affect their care. The f…
Matched conditions: COVID-19
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
COVID-19 may worsen radiation side effects in breast cancer patients
Knowledge-focused Not yet recruitingThis study examines whether having COVID-19 increases the chance of lung inflammation (radiation pneumonitis) in breast cancer patients receiving radiation therapy. Researchers will review medical records of 200 patients to compare outcomes between those who had COVID-19 and thos…
Matched conditions: COVID-19
Sponsor: Zhejiang Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC